Impact of Diagnosis to Treatment Interval in Patients With Newly Diagnosed MCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma
Blood Adv 2022 Dec 14;[EPub Ahead of Print], N Epperla, JM Switchenko, V Bachanova, JN Gerson, SK Barta, MJ Gordon, AV Danilov, NS Grover, SP Mathews, M Burkart, R Karmali, Y Sawalha, BT Hill, N Ghosh, SI Park, DA Bond, M Hamadani, TS Fenske, P Martin, J Guo, MK Malecek, BS Kahl, CR Flowers, BK Link, LD Kaplan, DJ Inwards, A Feldman, ED Hsi, K Maddocks, K Blum, NL Bartlett, JR Cerhan, JP Leonard, TM Habermann, MJ Maurer, JB CohenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.